United Kingdom· GB-APID-13296211000001105
Tiabendazole 500mg/5ml oral suspension
A tiabendazole product containing tiabendazole, registered in United Kingdom by Special Order.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Tiabendazole
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- P02CA02
- ATC class
- Tiabendazole
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
44 interactions on record for tiabendazole.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tiabendazole · interactions on record
44 records
- 2 severe
- 41 moderate
- 1 minor
Most severe, free to view
- TizanidineM03BX02severe
- RasagilineN04BD02severe
- AlosetronA03AE01moderate
- Obeticholic acidA05AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under P02CA02
Tiabendazole, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b51a141c-9607-4fd0-ba1a-dd331af128e7 GET /v1/drugs/b51a141c-9607-4fd0-ba1a-dd331af128e7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "13296211000001105",
"desc": "Tiabendazole 500mg/5ml oral suspension (Special Order)",
"form": "Oral suspension",
"vpid": "13304111000001101",
"source": "dmd",
"vtm_id": "777761007",
"strength": "100 mg",
"substance": "Tiabendazole",
"ingredient": "Tiabendazole",
"supplier_code": "8286711000001104"
}See everything about tiabendazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.